Intrathecal injection of metabotropic glutamate receptor subtype 3 and 5 agonist/antagonist attenuates bone cancer pain by inhibition of spinal astrocyte activation in a mouse model.

MLA

Ren BX, et al. “Intrathecal Injection of Metabotropic Glutamate Receptor Subtype 3 and 5 Agonist/Antagonist Attenuates Bone Cancer Pain by Inhibition of Spinal Astrocyte Activation in a Mouse Model.” Anesthesiology, vol. 116, no. 1, Jan. 2012, pp. 122–32. EBSCOhost, https://doi.org/10.1097/aln.0b013e31823de68d.

APA

Ren BX, Gu XP, Zheng YG, Liu CL, Wang D, Sun YE, & Ma ZL. (2012). Intrathecal injection of metabotropic glutamate receptor subtype 3 and 5 agonist/antagonist attenuates bone cancer pain by inhibition of spinal astrocyte activation in a mouse model. Anesthesiology, 116(1), 122–132. https://doi.org/10.1097/aln.0b013e31823de68d

Chicago

Ren BX, Gu XP, Zheng YG, Liu CL, Wang D, Sun YE, and Ma ZL. 2012. “Intrathecal Injection of Metabotropic Glutamate Receptor Subtype 3 and 5 Agonist/Antagonist Attenuates Bone Cancer Pain by Inhibition of Spinal Astrocyte Activation in a Mouse Model.” Anesthesiology 116 (1): 122–32. doi:10.1097/aln.0b013e31823de68d.